35 / 64
33
PROGRAMME & EXHIBITION GUIDE |
POSTERS
Radiation induced volume changes in salivary glands in head and neck
cancer patients receiving IMRT
D. Borade (India), M. Chandra, R. Bhalavat, L. Nellore, K. George,
K. Kalariya, V. Pareek, Z. Moosa, N. Reddy, A. Shrivastava
PO-094
Electrochemotherapy for mucosal head and neck tumours: results from a
phase II clinical trial.
C.C. Plaschke (Denmark), J. Gehl, H. Johannesen, H. Hendel, K. Kiss,
R. Hansen, I. Wessel
PO-095
Dosimetric evalutation of volumetric modulated arc therapy (VMAT) in
sinonasal cancer raiotherapy
E. Donini (Italy), S. Magi, S. Ricci, E. Pasquini, G. Frezza
PO-096
Poster
Biology, HPV and molecular targeting
Droplet digital PCR for detection of circulating tumour DNA in blood of
head and neck cancer patients
J.H. Van Ginkel (The Netherlands), M.M.H. Huibers, R.J.J. Van Es,
R. De Bree, S.M. Willems
PO-097
Searching for therapeutic targets from whole transcriptome of oral cancer
B. Roy (India), N. De Sarkar, R. Singh
PO-098
Human papillomavirus in head and neck cancer in the UK: a clinician
survey of current practice
B. Foran (UK), J. Fenwick, B. Byrne, J. Christian
PO-099
Oral cancer microenvironment - PI3K/AKT/mTOR and ERK/MAPK
pathways dependent targets
C. Domingues (Portugal), M. Laranjo, A.M. Abrantes, A.B. Sarmento-Ribeiro,
L. Carvalho, M.F. Botelho, H. Silva, M. Dourado
PO-100
Osteopontin (OPN) as an instant, predictive marker of tumour hypoxia in
head and neck cancer patients
J. Mrochem-Kwarciak (Poland), T. Rutkowski, A. Wygoda, R. Deja,
A. Hajduk, Ł. Boguszewicz, P. Widłak, K. Składowski
PO-101